Conatus Pharmaceuticals Inc

(NASDAQ:CNAT)

Latest On Conatus Pharmaceuticals Inc (CNAT):

Date/Time Type Description Signal Details
2020-12-13 03:36 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 17:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-19 08:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:38 ESTFinancialsCompany financials have been released.Neutral
2020-07-10 08:28 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 08:24 ESTFinancialsCompany financials have been released.Neutral
2020-05-31 16:56 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 06:32 ESTInsider TradeSteven J Mento has directly acquired 65,000 shares and currently holds 71,000 shares.Buy
2020-05-27 06:32 ESTInsider TradeAlfred P. Spada has directly acquired 31,343 shares and currently holds 32,555 shares.Buy
2020-05-27 06:32 ESTInsider TradeKeith W Marshall has directly acquired 38,500 shares and currently holds 38,500 shares.Buy
2020-05-03 23:28 ESTNewsConatus Pharmaceuticals reports Q1 resultsN/A
2020-05-03 08:30 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 00:25 ESTFinancialsCompany financials have been released.Neutral
2020-04-11 08:41 ESTNewsConatus Pharmaceuticals reports Q4 resultsN/A
2020-04-07 12:26 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 00:35 ESTFinancialsCompany financials have been released.Neutral
2020-03-13 00:23 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 23:27 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:28 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 23:22 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 23:21 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 23:24 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 23:24 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 03:29 ESTEarningsEarnings have been released on March 16, 2017, with -$0.35 earnings per share.Sell
2020-01-28 03:29 ESTEarningsEarnings have been released on November 6, 2019, with -$0.10 earnings per share.Buy
2020-01-28 03:29 ESTEarningsEarnings have been released on March 11, 2019, with -$0.13 earnings per share.Buy
2020-01-27 23:22 ESTFinancialsCompany financials have been released.Neutral
2020-01-15 23:23 ESTFinancialsCompany financials have been released.Neutral
2019-12-21 23:15 ESTFinancialsCompany financials have been released.Neutral
2019-12-16 23:23 ESTFinancialsCompany financials have been released.Neutral
2019-11-27 23:22 ESTFinancialsCompany financials have been released.Neutral
2019-11-26 23:22 ESTFinancialsCompany financials have been released.Neutral
2019-11-22 23:20 ESTFinancialsCompany financials have been released.Neutral
2019-11-15 23:22 ESTFinancialsCompany financials have been released.Neutral
2019-11-12 23:15 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on March 31, 2020.Sell
2019-11-08 23:15 ESTFinancialsCompany financials have been released.Neutral
2019-11-06 23:21 ESTFinancialsCompany financials have been released.Neutral
2019-11-05 20:20 ESTNewsConatus Pharmaceuticals EPS beats by $0.02, misses on revenueN/A
2019-08-06 01:05 ESTEarningsEarnings have been released on August 6, 2019, with -$0.02 earnings per share.Buy
2019-06-30 01:05 ESTFinancialsCompany financials have been released.Neutral
2019-03-31 01:05 ESTFinancialsCompany financials have been released.Neutral
2019-03-08 00:05 ESTEarningsEarnings have been released on March 8, 2019, with -$0.14 earnings per share.Sell
2018-12-31 00:05 ESTFinancialsCompany financials have been released.Neutral
2018-11-14 00:05 ESTInsider TradeEdward F III Smith has directly acquired 1,724 shares and currently holds 10,875 shares.Buy
2018-11-14 00:05 ESTInsider TradeDANIEL L. RIPLEY has indirectly acquired of 1,861 shares.Buy
2018-11-01 01:05 ESTEarningsEarnings have been released on November 1, 2018, with -$0.15 earnings per share.Neutral
2018-09-30 01:05 ESTFinancialsCompany financials have been released.Neutral

About Conatus Pharmaceuticals Inc (CNAT):

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidate includes Emricasan, an orally active caspase protease inhibitor that is in Phase IIb clinical trials for post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response; for portal hypertension; for liver fibrosis caused by nonalcoholic steatohepatitis; and for liver function. The company is also developing CTS-2090, an orally active inhibitor of caspase 1, which is in preclinical development stage for treating chronic diseases involving inflammasome pathways. The company has a collaboration agreement with Novartis to conduct three Phase IIb clinical trials. Conatus Pharmaceuticals Inc. was founded in 2005 and is headquartered in San Diego, California.

CNAT Quotes by TradingView

See Advanced Chart

General

  • Name Conatus Pharmaceuticals Inc
  • Symbol CNAT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 5
  • Fiscal Year EndDecember
  • IPO Date2013-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.conatuspharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1.26
  • Price/Book (Most Recent Quarter) 1.05
  • Enterprise Value Revenue 0.04
  • Enterprise Value EBITDA 0.19
View More

Financials

  • Most Recent Quarter 2020-03-31
  • Profit Margin -69%
  • Operating Margin -73%
  • Return on Assets -22%
  • Return on Equity -49%
  • Revenue 14.69 million
  • Earnings Per Share -$0.44
  • Revenue Per Share $0.44
  • Gross Profit -1810000
  • Quarterly Earnings Growth -92.9%
View More

Highlights

  • Market Capitalization 18.44 million
  • EBITDA -14363000
  • PEG Ratio -0.26
  • Analyst Target Price $1.6
  • Book Value Per Share $0.53
View More

Share Statistics

  • Shares Outstanding 33.17 million
  • Shares Float 32.34 million
  • % Held by Insiders 280%
  • % Held by Institutions 13.92%
  • Shares Short 130661
  • Shares Short Prior Month 146024
  • Short Ratio 0.37
View More

Technicals

  • Beta 1.84
  • 52 Week High $7.2
  • 52 Week Low $0.45
  • 50 Day Moving Average 0.54
  • 200 Day Moving Average 0.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

Conatus Pharmaceuticals Inc (CNAT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Conatus Pharmaceuticals Inc (CNAT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-03-312020-05-01$N/A-$0.10
2019-12-312020-03-12$526000-$0.08
2019-09-302019-11-06$3.38 million-$0.10-$0.1216.67%
2019-06-302019-08-07$10.79 million-$0.02-$0.1283.33%
2019-03-312019-05-03$7.02 million-$0.14-$0.12-16.67%
2018-12-312019-03-11$7.41 million-$0.13-$0.147.14%
2018-09-302018-11-02$7.67 million-$0.15-$0.15-1.33%
2018-06-302018-08-02$8.77 million-$0.15-$0.2025.35%
2018-03-312018-05-03$9.74 million-$0.17-$0.171.76%
2017-12-312018-03-08$8.81 million-$0.15-$0.1714.65%
2017-09-302017-11-02$9.57 million-$0.13-$0.05-166.6%
2017-06-302017-08-03$10.01 million-$0.19-$0.17-13.35%
2017-03-312017-05-05$7 million-$0.14
2016-12-312017-03-16$799000-$0.35-$0.26-35%
2016-09-302016-11-09$N/A-$0.31-$0.349.88%
2016-06-302016-08-04$N/A-$0.30-$0.3820.95%
2016-03-312016-05-05$N/A-$0.35
2015-12-312016-03-10$N/A-$0.30
2015-09-302015-11-05$N/A-$0.31
2015-06-302015-08-06$N/A-$0.31
2015-03-312015-05-08$N/A-$0.38
2014-12-312015-03-12$N/A-$0.34
2014-09-302014-11-13$N/A-$0.42
2014-06-302014-08-14$N/A-$0.34
2014-03-312014-05-14$N/A-$0.34
2013-12-312014-03-28$N/A-$0.37
2013-09-302013-11-15$N/A-$0.28
2013-06-302013-09-10$N/A$0.16

Conatus Pharmaceuticals Inc (CNAT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Conatus Pharmaceuticals Inc (CNAT) Chart:

Conatus Pharmaceuticals Inc (CNAT) News:

Below you will find a list of latest news for Conatus Pharmaceuticals Inc (CNAT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Conatus Pharmaceuticals Inc (CNAT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Conatus Pharmaceuticals Inc (CNAT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520181139/0001193125-20-181139-index.htm
2020-03-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1383701/000000000020002058/0000000000-20-002058-index.htm
2020-08-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1383701/000000000020007877/0000000000-20-007877-index.htm
2018-02-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1383701/000021545718004566/0000215457-18-004566-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1383701/000021545718005869/0000215457-18-005869-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1383701/000021545719006713/0000215457-19-006713-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1383701/000021545719007712/0000215457-19-007712-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014288/0000899243-20-014288-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014290/0000899243-20-014290-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014293/0000899243-20-014293-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014451/0000899243-20-014451-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014452/0000899243-20-014452-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014454/0000899243-20-014454-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014456/0000899243-20-014456-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014459/0000899243-20-014459-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014462/0000899243-20-014462-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014463/0000899243-20-014463-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014464/0000899243-20-014464-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014468/0000899243-20-014468-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014470/0000899243-20-014470-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014471/0000899243-20-014471-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014472/0000899243-20-014472-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014475/0000899243-20-014475-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014477/0000899243-20-014477-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014479/0000899243-20-014479-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014480/0000899243-20-014480-index.htm
2020-05-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014545/0000899243-20-014545-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000089924320014546/0000899243-20-014546-index.htm
2017-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184317005351/0001171843-17-005351-index.htm
2017-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184317006486/0001171843-17-006486-index.htm
2018-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318000882/0001171843-18-000882-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318001755/0001171843-18-001755-index.htm
2018-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318002527/0001171843-18-002527-index.htm
2018-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318003332/0001171843-18-003332-index.htm
2018-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318004815/0001171843-18-004815-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318005617/0001171843-18-005617-index.htm
2018-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318006531/0001171843-18-006531-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318007474/0001171843-18-007474-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318008331/0001171843-18-008331-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184318008332/0001171843-18-008332-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319001602/0001171843-19-001602-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319001889/0001171843-19-001889-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319002190/0001171843-19-002190-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319002867/0001171843-19-002867-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319003741/0001171843-19-003741-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319004145/0001171843-19-004145-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319004288/0001171843-19-004288-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319005210/0001171843-19-005210-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319007181/0001171843-19-007181-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319007632/0001171843-19-007632-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184319008300/0001171843-19-008300-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184320001652/0001171843-20-001652-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000117184320003170/0001171843-20-003170-index.htm
2020-05-01425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000117184320003171/0001171843-20-003171-index.htm
2017-11-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1383701/000119312517337229/0001193125-17-337229-index.htm
2018-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1383701/000119312518033096/0001193125-18-033096-index.htm
2018-03-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1383701/000119312518077337/0001193125-18-077337-index.htm
2018-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1383701/000119312518139072/0001193125-18-139072-index.htm
2018-08-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1383701/000119312518236596/0001193125-18-236596-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1383701/000119312519126925/0001193125-19-126925-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312519147983/0001193125-19-147983-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312519209639/0001193125-19-209639-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312519253568/0001193125-19-253568-index.htm
2019-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312519262731/0001193125-19-262731-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312519287314/0001193125-19-287314-index.htm
2019-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312519302624/0001193125-19-302624-index.htm
2020-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520016930/0001193125-20-016930-index.htm
2020-01-28425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520016931/0001193125-20-016931-index.htm
2020-01-28425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520017114/0001193125-20-017114-index.htm
2020-01-30425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520019095/0001193125-20-019095-index.htm
2020-01-30425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520019101/0001193125-20-019101-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520025220/0001193125-20-025220-index.htm
2020-02-06425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520026229/0001193125-20-026229-index.htm
2020-02-07S-4Registration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520028298/0001193125-20-028298-index.htm
2020-03-13S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520073055/0001193125-20-073055-index.htm
2020-03-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1383701/000119312520073097/0001193125-20-073097-index.htm
2020-03-30S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520091055/0001193125-20-091055-index.htm
2020-03-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1383701/000119312520091070/0001193125-20-091070-index.htm
2020-04-01424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1383701/000119312520094708/0001193125-20-094708-index.htm
2020-04-06425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520098969/0001193125-20-098969-index.htm
2020-04-15425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520107673/0001193125-20-107673-index.htm
2020-04-20425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520111604/0001193125-20-111604-index.htm
2020-04-22425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520115040/0001193125-20-115040-index.htm
2020-05-01425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520129812/0001193125-20-129812-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520136238/0001193125-20-136238-index.htm
2020-05-07425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520136240/0001193125-20-136240-index.htm
2020-05-11425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520138321/0001193125-20-138321-index.htm
2020-05-11425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520139036/0001193125-20-139036-index.htm
2020-05-14425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520142782/0001193125-20-142782-index.htm
2020-05-18425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520145029/0001193125-20-145029-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520148679/0001193125-20-148679-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520152366/0001193125-20-152366-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520153827/0001193125-20-153827-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520156548/0001193125-20-156548-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520162163/0001193125-20-162163-index.htm
2020-06-268-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520181137/0001193125-20-181137-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1383701/000119312520181139/0001193125-20-181139-index.htm
2020-07-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1383701/000119312520195506/0001193125-20-195506-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520195522/0001193125-20-195522-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520213704/0001193125-20-213704-index.htm
2020-08-17S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1383701/000119312520222488/0001193125-20-222488-index.htm
2020-08-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1383701/000119312520228320/0001193125-20-228320-index.htm
2020-08-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1383701/000119312520233284/0001193125-20-233284-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520233288/0001193125-20-233288-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000119312520257231/0001193125-20-257231-index.htm
2017-09-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919117051050/0001209191-17-051050-index.htm
2017-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919117051052/0001209191-17-051052-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007553/0001209191-18-007553-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007556/0001209191-18-007556-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007558/0001209191-18-007558-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007561/0001209191-18-007561-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007562/0001209191-18-007562-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007563/0001209191-18-007563-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007564/0001209191-18-007564-index.htm
2018-02-055Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118007565/0001209191-18-007565-index.htm
2018-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118014949/0001209191-18-014949-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118028454/0001209191-18-028454-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118039395/0001209191-18-039395-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118039396/0001209191-18-039396-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118039397/0001209191-18-039397-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118039398/0001209191-18-039398-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118039399/0001209191-18-039399-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919118039400/0001209191-18-039400-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008917/0001209191-19-008917-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008920/0001209191-19-008920-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008922/0001209191-19-008922-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008924/0001209191-19-008924-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008925/0001209191-19-008925-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008929/0001209191-19-008929-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119008930/0001209191-19-008930-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119039725/0001209191-19-039725-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119039729/0001209191-19-039729-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119039731/0001209191-19-039731-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119039732/0001209191-19-039732-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119039734/0001209191-19-039734-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119044008/0001209191-19-044008-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119044011/0001209191-19-044011-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119044012/0001209191-19-044012-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119044014/0001209191-19-044014-index.htm
2019-11-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119057122/0001209191-19-057122-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919119057129/0001209191-19-057129-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054432/0001209191-20-054432-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054434/0001209191-20-054434-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054435/0001209191-20-054435-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054436/0001209191-20-054436-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054437/0001209191-20-054437-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054441/0001209191-20-054441-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120054445/0001209191-20-054445-index.htm
2020-10-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120055258/0001209191-20-055258-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1383701/000120919120055262/0001209191-20-055262-index.htm
2017-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459017021246/0001564590-17-021246-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1383701/000156459018004914/0001564590-18-004914-index.htm
2018-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459018010665/0001564590-18-010665-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459018018892/0001564590-18-018892-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459018026299/0001564590-18-026299-index.htm
2019-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1383701/000156459019007030/0001564590-19-007030-index.htm
2019-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459019015689/0001564590-19-015689-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459019030048/0001564590-19-030048-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459019040404/0001564590-19-040404-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1383701/000156459020010122/0001564590-20-010122-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000156459020014191/0001564590-20-014191-index.htm
2020-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459020020517/0001564590-20-020517-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1383701/000156459020040018/0001564590-20-040018-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1383701/000156459020040035/0001564590-20-040035-index.htm
2017-11-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1383701/999999999517002939/9999999995-17-002939-index.htm
2020-04-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1383701/999999999520000660/9999999995-20-000660-index.htm
2020-08-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1383701/999999999520002269/9999999995-20-002269-index.htm
2020-07-31CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1383701/999999999720004234/9999999997-20-004234-index.htm

Conatus Pharmaceuticals Inc (CNAT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Conatus Pharmaceuticals Inc (CNAT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 280%
Institutional Ownership: 1392%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-11-14Edward F III SmithSVP, Reg Affairs and QABuy1,724.003.155,430.6010,875.00https://www.sec.gov/Archives/edgar/data/1383701/000120919119008925/0001209191-19-008925-index.htm
2018-02-27Alfred P. SpadaEVP, R&D and CSOBuy12,121.001.2415,030.0412,121.00https://www.sec.gov/Archives/edgar/data/1383701/000120919118014949/0001209191-18-014949-index.htm
2017-05-12DANIEL L. RIPLEYSVP, Bus Dev, P&A MgmtBuy761.001.701,293.7028,462.00https://www.sec.gov/Archives/edgar/data/1383701/000120919118007561/0001209191-18-007561-index.htm
2017-11-14DANIEL L. RIPLEYSVP, Bus Dev, P&A MgmtBuy818.003.482,846.6429,280.00https://www.sec.gov/Archives/edgar/data/1383701/000120919118007561/0001209191-18-007561-index.htm
2018-05-14DANIEL L. RIPLEYSVP, Bus Dev, P&A MgmtBuy1,290.003.314,269.9030,570.00https://www.sec.gov/Archives/edgar/data/1383701/000120919119008924/0001209191-19-008924-index.htm
2018-11-14DANIEL L. RIPLEYSVP, Bus Dev, P&A MgmtBuy1,861.003.155,862.1532,431.00https://www.sec.gov/Archives/edgar/data/1383701/000120919119008924/0001209191-19-008924-index.htm
2020-05-22Alfred P. SpadaEVP, R&D and CSOBuy31,343.0032,555.00https://www.sec.gov/Archives/edgar/data/1383701/000089924320014290/0000899243-20-014290-index.htm
2020-05-22Keith W MarshallEVP, COO & CFOBuy38,500.0038,500.00https://www.sec.gov/Archives/edgar/data/1383701/000089924320014293/0000899243-20-014293-index.htm
2017-11-14Edward F III SmithSVP, Reg Affairs and QABuy4,461.003.4815,524.284,461.00https://www.sec.gov/Archives/edgar/data/1383701/000120919118007562/0001209191-18-007562-index.htm
2018-05-04Steven J MentoPresident, CEO & DirectorBuy60,000.000.9959,400.0060,000.00https://www.sec.gov/Archives/edgar/data/1383701/000120919118028454/0001209191-18-028454-index.htm
2020-05-22Steven J MentoDirectorBuy65,000.0071,000.00https://www.sec.gov/Archives/edgar/data/1383701/000089924320014288/0000899243-20-014288-index.htm
2018-05-14Edward F III SmithSVP, Reg Affairs and QABuy4,690.003.3115,523.909,151.00https://www.sec.gov/Archives/edgar/data/1383701/000120919119008925/0001209191-19-008925-index.htm